Today the Vaccine Research Institute (VRI) in Créteil near Paris started to recruit 100 volunteers to evaluate a preventive HIV candidate vaccine. An innovative vaccine trial was launched by the VRI and the French National Agency for Research on AIDS and Hepatitis (ANRS). It will be based in four centres. It will be the first to test the immunological effectiveness of three already proven “candidate vaccines” by combining them in pairs. This trial method using four different combinations of vaccines targets a more effective vaccine.


For further information, visit the Vaccine Research Institute (VRI) site